Genomate Health is proud to announce its participation in Ci4CC’s 23rd Cancer Center Summit, themed "Accelerating Innovation in Oncology through AI". The event will take place from May 16–18, 2025, in San Diego, California. As a leader in computational reasoning solutions for precision oncology, Genomate Health joins this prestigious event to further its mission of transforming cancer care and advancing personalized medicine.

Representing Genomate Health at the summit will be CEO Nabil Hafez, MS, MBA, and CSO Istvan Petak, MD, PhD. As pioneers in computational reasoning for precision oncology, both leaders will share their insights on leveraging algorithms to predict patient responses to targeted therapies. Through this innovative approach, Genomate® empowers oncologists with robust, data-driven insights to personalize cancer treatment and improve patient outcomes.

Dr. Istvan Petak, a visionary in the field of computational oncology, will share his latest research and insights into how computational reasoning is revolutionizing cancer care. Nabil Hafez, with his extensive experience in healthcare innovation, will discuss Genomate Health’s approach to addressing the challenges faced by oncologists when making treatment decisions.

We warmly invite all attendees to visit booth #15 and connect with our team during the summit. Discover how Genomate Health’s innovative solutions reshape cancer care through precision and computational insights. 

‍

About the Ci4CC Cancer Center Summit

The 23rd Cancer Center Summit serves as a vital gathering for industry leaders, researchers, and healthcare professionals to explore the latest innovations in oncology. By participating in this event, Genomate Health demonstrates its commitment to advancing precision oncology through cutting-edge computational technologies. Engaging with experts at this summit will foster collaborations that accelerate the global adoption of personalized cancer care practices.

‍